Argenx price target raised to $639 from $547 at Wells Fargo
The Fly

Argenx price target raised to $639 from $547 at Wells Fargo

Wells Fargo analyst Derek Archila raised the firm’s price target on Argenx (ARGX) to $639 from $547 and keeps an Overweight rating on the shares. The firm’s initial read on Vyvgart’s chronic inflammatory demyelinating polyneuropathy revenue contribution during the quarter was too bullish, but the launch looks solid, the analyst tells investors in a research note.

Don't Miss out on Research Tools:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App